NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Sep 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
16
Data completeness
4/8 — Partial
SANCUSO (granisetron) by Cumberland Pharmaceuticals is serotonin 3 receptor antagonists [moa]. First approved in 2008.
Drug data last refreshed 26m ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SANCUSO is a transdermal extended-release film formulation of granisetron, a serotonin-3 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting (CINV). The drug works by blocking serotonin receptors in the chemoreceptor trigger zone and gastrointestinal tract. It is approved for patients receiving emetogenic cancer chemotherapy.
$7.0MPart D
LOE ApproachingWith LOE approaching and modest Part D spending of $7M annually, this product is in defensive mode with a small, specialized team focused on retention rather than expansion.
Mechanism of Action
Serotonin 3 Receptor Antagonists
Pharmacologic Class:
Serotonin-3 Receptor Antagonist
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (16)
Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites
Started Oct 2021
66 enrolled
Healthy Volunteers
Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.
Started Jul 2021
134 enrolled
Healthy Volunteers
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting
Started Aug 2020
0Chemotherapy-induced Nausea and Vomiting
Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
Started Jan 2019
0Gastroparesis
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Started Mar 2014
942 enrolled
Chemotherapy-induced Nausea and Vomiting
Worked on SANCUSO at Cumberland Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.